News
Royalty Pharma shares surge 59% after $2.2 billion IPO
Biopharma initial public offerings are back with a bang after a …
21275 items found
News
FDA approves Akili's video game ADHD therapy
The FDA has approved the first video game-based treatment for …
News
Analysts tip Inventiva's lanifibranor as NASH blockbuster
Inventiva’s lanifibranor has been tipped to become a blockbuster in …
News
NICE rejects Sanofi's Cablivi for rare blood disorder TTP
NICE has rejected Sanofi’s Cablivi (caplacizumab) for the rare blood …
News
AZ promises to deliver 400m doses of COVID-19 vaccine to Europe
AstraZeneca has followed through on its pledge to provide its …
News
NICE backs funding for Roche's lung cancer drug after price cut
NICE has recommended NHS funding for Roche’s Rozlytrek (entrectinib) …
News
Novo Nordisk diversifies with $2.1bn deal to buy Corvidia
Novo Nordisk has taken another step towards expanding beyond its …
News
AI chatbot aims to fight social isolation in older people
Specialist investor Startup Health has backed an artificial …
Views & Analysis
Talking vaccines: Industry’s role in protecting the Gavi generation
A new report highlights the important work of companies across the …
News
Agios up as FDA gives Thermo Fisher glioma test breakthrough status
Shares in Agios Pharma ticked upwards after the FDA awarded …
News
Lilly takes AI-selected Olumiant into phase 3 for COVID-19
Eli Lilly has enrolled the first patient into a phase 3 trial that is …
Views & Analysis
The unprecedented challenge of pricing a coronavirus vaccine
The optimal pricing strategy for a new vaccine involves setting a …
News
UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer
AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
Revolutionising Clinical Trials: Evolution Summit 2025 Retur...
Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers
R&D
Partner Content
Welcome to the 3rd Spatial Biology for Drug Development Summ...
Transforming Research & Development with Faster, More Precise Spatial Insights